Since July 2000 Boehringer
Ingelheim International GmbH has offered its antiretroviral
drug Viramune®
free of charge to developing countries for the prevention
of mother-to-child transmission of HIV-1. The donations are
available to any governments, non-governmental
organizations, charitable organizations or healthcare
providers with comprehensive PMTCT
programmes.
For more information, please see:
To apply to Abbott's PMTCT Donation
Program for the DetermineŽ HIV - 1/2 rapid test kit, please
refer to the following site:
www.directrelief.org
WHO HIV/AIDS site: Guidelines for treating Mother-To-Child transmission
